中国医院用药评价与分析2025，Vol.25Issue(2)：215-219,222,6.DOI:10.14009/j.issn.1672-2124.2025.02.019
司美格鲁肽注射液的多属性临床综合评价
Multi-Aattribute Clinical Comprehensive Evaluation of Smegglutide Injection
摘要
Abstract
OBJECTIVE:To perform the multi-attribute clinical comprehensive evaluation of semaglutide injection,so as to provide reference for the selection of the drug in medical institutions.METHODS:Base on the Guidelines for the Management of Clinical Comprehensive Evaluation of Drugs(Trial Version 2021)and referring to the evaluation system,retrieval strategies,dimensions,elements,weights of drug evaluation and selection recommended in the the Quick Guideline for Drug Evaluation and Selection in Chinese Medical Institutions(the Second Edition),the pharmaceutical characteristics,efficacy,safety,economy,and other attributes of semaglutide injection were evaluated.RESULTS:The total score of semaglutide injection was 68.05 points,including 23 points for pharmaceutical characteristics,23 points for efficacy score,13 points for safety score,3.55 points for economy score,and 5.5 points for other attribute score.The evaluation results showed that semaglutide had good safety and efficacy.In terms of economy,due to the short market time and high unit price,the economy needed to be improved.In terms of other attributes,semaglutide was the class B medical insurance drug with guaranteed sales conditions and was not the national essential drug,which could affect the clinical application.CONCLUSIONS:The multi-attribute score of semaglutide was 68.05 points,which can be improved to be strong clinical recommendation in terms of safety,economy and other attributes.关键词
司美格鲁肽/胰高血糖素样肽-1/药品评价/药品遴选Key words
Semaglutide/Glucagon-like peptide-1/Drug evaluation/Drug selection分类
医药卫生引用本文复制引用
马雅斌,陈丹霞,鲍思蔚,范秀丛,赵月芬..司美格鲁肽注射液的多属性临床综合评价[J].中国医院用药评价与分析,2025,25(2):215-219,222,6.基金项目
上海市药学会基金项目(No.SHYXH-ZP-2021-013) （No.SHYXH-ZP-2021-013）
